Cancer Research

Mitchell Cancer Institute (MCI) Earns Accreditation

Mitchell Cancer Institute (MCI) Earns Accreditation

July 8, 2022
In

MOBILE, Ala. — The USA Health MCI has again earned a three-year accreditation from the Commission on Cancer (CoC), which recognizes excellence in the delivery of comprehensive, patient-centered cancer care. The oncology program at USA Health (including MCI since it opened in 2008) has been accredited since 1976. The CoC Accreditation Program provides the framework…

USA Health Research Published In British Journal

USA Health Research Published In British Journal

January 14, 2022
In

Researchers at the USA Health Mitchell Cancer Institute (MCI) and the University of South Alabama (USA) College of Medicine uncovered a novel mechanism that underlies castration therapy resistance in metastatic prostate cancer. Their findings were published recently in the British Journal of Cancer. Dr. Mohammad Aslam Khan, a senior research associate at MCI, is one…

USA Health Cervical Cancer Research Awarded Grant

USA Health Cervical Cancer Research Awarded Grant

January 7, 2022
In

Dr. Santanu Dasgupta, a cancer researcher at the USA Health Mitchell Cancer Institute (MCI) and assistant professor of pathology at the University of South Alabama (USA) College of Medicine, recently received a $126,000 grant from the Elsa U. Pardee Foundation to identify certain stress-related factors that aid in initiation and progression of cervical cancer. In…

USA Scientists Publish “Breakthrough Research”

USA Scientists Publish “Breakthrough Research”

December 17, 2021
In ,

The University of South Alabama (USA) has announced a discovery by scientists at its College of Medicine that may provide further understanding of genes and factors that cause cancers in relation to DNA damage. An article about the discovery was recently published in the scientific journal Cell Reports. “This breakthrough research uses state-of-the-art microscopy and…

USA Health Researcher Collaborates to Treat Cancer

USA Health Researcher Collaborates to Treat Cancer

December 11, 2020
In

Dr. Gary Piazza, professor of pharmacology at the University of South Alabama (USA) College of Medicine and co-lead investigator, is part of a collaboration to explore a potential treatment for aggressive cancers and discovered and developed a novel RAS inhibitor class. RAS inhibitors may help treat aggressive RAS-driven cancers such as pancreatic, colon and lung…

Ready to Subscribe?

Get weekly updates delivered right to your inbox.